Development of mucoadhesive dosage forms of buprenorphine for sublingual drug delivery.
The development of mucoadhesive formulations of buprenorphine for intended sublingual usage in the treatment of drug addiction is described. The formulations include mucoadhesive polymer films, with or without plasticizers, and mucoadhesive polymer tablets, with or without excipients that enhance drug release and/or improve tablet compaction properties. The mucoadhesive polymers studied include carbomers such as Carbopol 934P, Carbopol 974P, and the polycarbophil Noveon AA-1, with excipients chosen from pregelatinized starch, lactose, glycerol, propylene glycol, and various molecular weights of polyethylene glycol. The development of plasticizer-containing mucoadhesive polymer films was feasible; however, these films failed to release their entire drug content within a reasonable period. Thus, they were not determined suitable for sublingual usage because of possible loss by ingestion during routine meal intakes. The mucoadhesive strength of tablet formulations containing Noveon AA-1 appears to be slightly superior to the Carbopol-containing tablets. However, the Carbopol 974P formulations exhibited superior drug dissolution profiles while providing adequate mucoadhesive strength. The tablet formulations containing Carbopol 974P as mucoadhesive polymer, lactose as drug release enhancer, and PEG 3350 as compaction enhancer exhibited the best results. Overall, the mucoadhesive tablet formulations exhibited superior results compared with the mucoadhesive film formulations.
Das
Nandita G
NG
Idaho State University, College of Pharmacy, Pocatello, Idaho 83209-8334, USA. das@pharmacy.isu.edu
Das
Sudip K
SK
D000269:Adhesives / Q000008:administration & dosage* / Q000737:chemistry; D000286:Administration, Sublingual; D002047:Buprenorphine / Q000008:administration & dosage* / Q000737:chemistry; D004304:Dosage Forms; D016503:Drug Delivery Systems / Q000379:methods*; D012995:Solubility; D013607:Tablets
D000269:Adhesives; D004304:Dosage Forms; D013607:Tablets; D002047:Buprenorphine